MC
GILD icon

Middleton & Co’s Gilead Sciences GILD Stock Holding History

Middleton & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,530
Closed -$221K – 139
2018
Q4 		$221K Sell
3,530
-14,139
-80% -$988K 0.04% 134
2018
Q3 		$1.36M Sell
17,669
-1,800
-9% -$136K 0.21% 88
2018
Q2 		$1.38M Sell
19,469
-20,363
-51% -$1.44M 0.24% 86
2018
Q1 		$3M Sell
39,832
-30,824
-44% -$2.45M 0.54% 60
2017
Q4 		$5.06M Sell
70,656
-32,752
-32% -$2.49M 0.85% 45
2017
Q3 		$8.38M Buy
103,408
+10,680
+12% +$817K 1.51% 19
2017
Q2 		$6.56M Sell
92,728
-11,703
-11% -$779K 1.4% 25
2017
Q1 		$7.09M Sell
104,431
-6,657
-6% -$468K 1.56% 18
2016
Q4 		$7.96M Buy
111,088
+1,132
+1% +$84.1K 1.8% 16
2016
Q3 		$8.7M Sell
109,956
-4,473
-4% -$363K 1.95% 14
2016
Q2 		$9.55M Sell
114,429
-1,252
-1% -$111K 2.19% 10
2016
Q1 		$10.6M Sell
115,681
-7,512
-6% -$677K 2.46% 8
2015
Q4 		$12.5M Sell
123,193
-6,008
-5% -$625K 2.78% 5
2015
Q3 		$12.7M Buy
129,201
+1,049
+0.8% +$117K 3.01% 5
2015
Q2 		$15M Buy
128,152
+2,178
+2% +$238K 3.25% 2
2015
Q1 		$12.4M Sell
125,974
-4,205
-3% -$427K 2.7% 4
2014
Q4 		$12.3M Sell
130,179
-5,565
-4% -$576K 2.75% 4
2014
Q3 		$14.4M Sell
135,744
-14,428
-10% -$1.41M 3.39% 2
2014
Q2 		$12.5M Buy
150,172
+3,011
+2% +$234K 2.83% 3
2014
Q1 		$10.4M Buy
147,161
+19,918
+16% +$1.56M 2.43% 4
2013
Q4 		$9.56M Buy
127,243
+2,455
+2% +$171K 2.5% 6
2013
Q3 		$7.84M Buy
124,788
+6,523
+6% +$390K 2.06% 10
2013
Q2 		$6.06M Buy
+118,265
New +$6.16M 1.78% 19

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Middleton & Co's GILD Position: Q1 2019 in Review

Middleton & Co sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 3,530 shares — an estimated $221K sold.

Middleton & Co first reported a position in GILD in Q2 2013 and held it in 23 quarters. The position peaked at $15M in Q2 2015. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Middleton & Co reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • Middleton & Co sold 3,530 Gilead Sciences shares in Q1 2019, an estimated $221K.
  • Middleton & Co first reported a position in Gilead Sciences in Q2 2013 and held it in 23 quarters.
  • Middleton & Co's Gilead Sciences position peaked at $15M in Q2 2015.
  • 1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Middleton & Co's 13F filing for Q1 2019, filed 25 Apr 2019.